Status | Study |
Not yet recruiting |
Study Name: Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection Condition: Genital Herpes HSV-2 Infection Date: 2017-05-05 Interventions: Biological: GEN-003 HSV-2 prot |
Active, not recruiting |
Study Name: Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity Condition: Genital Herpes Simplex Type 2 Date: 2016-09-09 Interventions: Biological: Observational |
Active, not recruiting |
Study Name: Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine Condition: Herpes Genitalis Date: 2016-07-13 Interventions: Biological: VCL-HB01 Investiga |
Active, not recruiting |
Study Name: Evaluating New Formulation of Therapeutic HSV-2 Vaccine Condition: Genital Herpes Simplex Type 2 Date: 2015-07-31 Interventions: Biological: Matrix-M2 Matrix-M |
Completed |
Study Name: Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study Condition: Genital Herpes Simplex Type 2 Date: 2014-11-20 Interventions: Biological: Matrix-M2 Adjuvant |
Completed |
Study Name: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Condition: Genital Herpes Simplex Type 2 Date: 2014-04-11 Interventions: Biological: Matrix-M2 Adjuvant |
Completed |
Study Name: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults Condition: Genital Herpes Simplex Type 2 Date: 2013-12-20 Interventions: Biological: VCL-HB01 Plasmid D |
Terminated |
Study Name: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes Condition: Genital Herpes Date: 2012-12-14 Interventions: Drug: PEG-Formulation |
Completed |
Study Name: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine Condition: Genital Herpes Simplex Type 2 Date: 2012-08-14 Interventions: Biological: GEN-003 with Matrix M-2 |
Terminated |
Study Name: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes Condition: Genital Herpes Date: 2012-08-03 Interventions: Drug: AIC316 oral administrati |